AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48 | -68.2% | 0 | -100.0% | 0.00% | – |
| Q2 2023 | $151 | +202.0% | 72 | +16.1% | 0.00% | -100.0% |
| Q1 2023 | $50 | -67.7% | 62 | -19.5% | 0.00% | +100.0% |
| Q4 2022 | $155 | -99.6% | 77 | -43.0% | 0.00% | 0.0% |
| Q3 2022 | $36,000 | +9.1% | 135 | +13400.0% | 0.00% | -93.8% |
| Q3 2021 | $33,000 | -50.7% | 1 | 0.0% | 0.02% | -33.3% |
| Q2 2021 | $67,000 | – | 1 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |